You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Article Text

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

https://doi.org/10.1136/jitc-2021-002568corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Ferris RL, Spanos WC, Leidner R et al. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. J Immunother Cancer 2021;9:e002568. doi: 10.1136/jitc-2021-002568

    This paper has been revised since first published to update 'Acknowledgements'.